Drug intelligence / Profile preview

cannabielsoin

Development stage
Preclinical
Lead developer
Xinteza
Modality
Small Molecules
01

Overview

Cannabielsoin (CBE) is a non-psychoactive cannabinoid produced biosynthetically by Xinteza. It is a naturally occurring compound found in *Cannabis sativa*, where it primarily exists as a metabolite of cannabidiol (CBD). Xinteza utilizes a proprietary yeast-based biosynthesis platform to manufacture high-purity CBE for use as an active pharmaceutical ingredient (API). While the specific pharmacological profile of CBE is less extensively studied than major cannabinoids like THC or CBD, it is investigated for its potential interactions with the endocannabinoid system. Xinteza's business model focuses on the production and licensing of these rare cannabinoids as raw ingredients for pharmaceutical research and development rather than internal clinical development for specific therapeutic indications.

Other names
CBECannabielsoin
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on cannabielsoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cannabielsoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call